The GvHD Hub are proud to present expert interviews directly from the 61st American Society of Hematology (ASH) meeting in Orlando, US. In this interview, Mohamad Mohty, Saint-Antoine Hospital and Sorbonne University, Paris, FR, discusses practice-changing abstracts in the field of graft- versus-host disease that were presented during ASH 2019.
Mohamad Mohty talks about the benefits of stem cell transplantations and explains that it comes at a cost of complications such as graft- versus-host disease. He also discusses different prophylaxis regimens that are offered to patients and how that affects patient responses. He talks about the success of post-transplant cyclophosphamide in the haploidentical setting and questions its efficacy if it were to be translated into the identical sibling/unrelated setting. He also discusses the anticipated results of the HOVON trial. He concludes by discussing novel interventions such as the use of fecal microbiota transplant.